Thermo Fisher (TMO) vs Danaher (DHR): Which Life Sciences Stock Looks Better Positioned?
Thermo Fisher Scientific Inc.
Danaher Corp (DHR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Generation Investment Management David Blood And Al Gore | 6,761,596 | $1,287,948,806 | -8% | 12.52% |
| 2. | Fisher Asset Management Ken Fisher | 4,484,774 | $854,260,080 | -3% | 0.25% |
| 3. | Lee Munder Capital Group Lee Munder | 124,427 | $23,700,870 | +15% | 1.27% |
| 4. | Bailard Inc Thomas Bailard | 66,702 | $12,705,407 | -2% | 0.26% |
| 5. | Bourgeon Capital John Zaro | 66,332 | $12,634,960 | +4% | 1.86% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $247.89 | 100 | $24,789.00 | 3,256 | 2022-05-16 | Filing | |
| $247.89 | 100 | $24,789.00 | 3,256 | 2022-05-16 | Filing | |
| $221.46 | 900 | $199,314.00 | 3,156 | 2021-02-26 | Filing | |
| $221.46 | 900 | $199,314.00 | 3,156 | 2021-02-26 | Filing | |
| $221.59 | 4,800 | $1,063,632.00 | 2,409,190 | 2021-02-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $174.67 | 1,358 | $237,206.88 | 124,094 | 2026-05-01 | Filing | |
| $208.01 | 1,320 | $274,574.52 | 5,099 | 2026-02-19 | Filing | |
| $231.19 | 4,726 | $1,092,603.94 | 850,000 | 2025-11-25 | Filing | |
| $230.27 | 35,899 | $8,266,462.73 | 854,726 | 2025-11-25 | Filing | |
| $226.50 | 3,298 | $746,997.00 | 20,762 | 2025-11-18 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 55,084,630 | $10,492,520,322 | 0.16% | |
| 2. | 28,456,019 | $5,431,565,288 | 0.16% | |
| 3. | 3,878,641 | $762,216,330 | 0.24% | |
| 4. | 3,923,035 | $747,259,707 | 3.38% | |
| 5. | 3,742,518 | $712,874,853 | 0.12% |
News See All
Abbott vs Danaher: Which Healthcare Stock Looks Better Positioned Following Earnings?
Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual profit forecast as robust demand for its cancer diagnostics and medical devices...
Danaher Beat Earnings Estimates, so Why Are Investors Still Concerned About Growth?
Danaher Corporation (NYSE:DHR) delivered second-quarter results on July 21, marked by core growth improving compared to the previous quarter, along with disciplined execution that drove high-single-digit...
Agilent Technologies (A) Expands Its Oncology Diagnostics Reach—Can Growth Keep Up?
Agilent Technologies Inc. (NYSE:A) just extended its diagnostics franchise into one of oncology's toughest corners.
Johnson & Johnson vs. Danaher: Which Healthcare Stock Looks Better Positioned Following Earnings?
Johnson & Johnson (NYSE:JNJ) delivered strong fiscal Q2 2026 results, with sales for the quarter growing nearly 7% to $25.31 billion, above analysts' average estimate of about $25.05 billion.
Jim Cramer Discussed 13 Stocks Like FedEx Freight and the Threat of Oversupply in the Market
In this article, we will look at the stocks Jim Cramer discussed during Mad Money, as he called the growing wave of stock offerings and debt issuance a threat to the bull market.
Is Danaher (DHR) One of the Best Non-Tech Stocks to Buy According to Analysts?
Danaher Corporation (NYSE:DHR) is one of the best non-tech stocks to buy according to analysts.
10 Best Long Term Stocks to Buy According to Hedge Funds
On June 25, Allan Small, Senior Investment Advisor at Allan Small Financial Group, appeared on BNN Bloomberg to discuss investment opportunities and talk about the state of the market, which is trading...
10 Best Non-Tech Stocks to Buy According to Analysts
On June 24, Tom Lee, Head of Research at Fundstrat Global Advisors, appeared on CNBC to talk about how the semiconductor selloff is a buying opportunity, earnings growth is supporting higher stocks, and...
HSBC Cuts PT on Danaher Corporation (DHR) - Here's Why
Danaher Corporation (NYSE:DHR) is one of the top high-conviction stocks to buy according to hedge funds.
Hedge Fund Resource Center